Abstract
In the years that have elapsed since the publication of the first volume, some strides have been made in defining certain aspects of the localization, metabolic clearance, and disposition of thyrotropin-releasing hormone (TRH). This is due in large part to the increasing availability of improved methods for the radioimmunoassay (RIA) of TRH. A detailed review on all aspects of TRH physiology has recently been published.1
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Jackson, I. M. D., 1982, Thyrotropin-releasing hormone, N. Engl. J. Med. 306: 145–155.
Kubek, M., Wilber, J. F., and George, J. M., 1979, The distribution and concentration of thyrotropin-releasing hormone in discrete human hypothalamic nuclei, Endocrinology 105: 537–540.
Aizawa, T., and Greer, M. A., 1981, Delineation of the hypothalamic area controlling thyrotropin secretion in the rat, Endocrinology 109: 1731–1738.
Engler, D., Scanlon, M. F., and Jackson, I. M. D., 1981, Thyrotropinreleasing hormone in the systemic circulation of the neonatal rat is derived from the pancreas and other extraneural tissues, J. Clin. Invest. 67: 800–808.
Shambaugh, G., III, Kubek, M., and Wilber, J. F., 1979, Thyrotropinreleasing hormone activity in the human placenta, J. Clin. Endocrinol. Metab. 48: 483–486.
Youngblood, W. W., Humm, J., Lipton, M. A., and Kizer, J. S., 1980, Thyrotropin-releasing hormone-like bioactivity in placenta: Evidence for the existence of substances other than Pyroglu-His-Pro-NH2 (TRH) capable of stimulating pituitary thyrotropin release, Endocrinology 106: 541–546.
Bhandaru, L., and Emerson, C. H., 1980, Evidence for the presence of the putative TRH metabolite, deamido-TRH, in human urine, J. Clin. Endocrinol. Metab. 51: 410–412.
Emerson, C. H., Vogel, W., Currie, B. L., and Okal, T., 1980, Concentrations of thyrotropin-releasing hormone (TRH) and deamido-TRH, and TRH deamidase activity in brain, Endocrinology 107: 443–449.
Yanagisawa, T., Prasad, C., and Peterkofsky, A., 1980, The subcellular and organ distribution and natural form of histidyl-proline diketopiperazine in rat brain determined by a specific radioimmunoassay, J. Biol. Chem. 255: 10290–10298.
Emerson, C. H., Alex, S., Braverman, L. E., and Safran, M. S., 1981, A study of the effect of the thyrotropin-releasing hormone metabolite, histidyl proline diketopiperazine, on prolactin in vivo, Endocrinology 109: 1375–1379.
Morley, J. E., Garvin, T. J., Pekary, A. E., Utiger, R. D., Nair, M. G., Baugh, C. M., and Hershman, J. M., 1979, Plasma clearance and plasma half-disappearance time of exogenous thyrotropin-releasing hormone and pyroglutamyl-N’-methyl-histidyl prolineamide, J. Clin. Endocrinol. Metab. 48: 377–380.
Emerson, C. H., Mishal, A., Mahabeer, H. L., and Currie, B. L., 1979, Lack of evidence for thyrotropin-releasing hormone deamidation in normal and hyperthyroid human sera, J. Clin. Endocrinol. Metab. 49: 138–140.
Jackson, I. M. D., Papapetrou, P. D., and Reichlin, S., 1979, Metabolic clearance of thyrotropin-releasing hormone in the rat in hypothyroid and hyperthyroid states: Comparison with serum degradation in vitro, Endocrinology 104: 1292–1298.
Naor, Z., Snyder, G., Fawcett, C. P., and McCann, S. M., 1980, Pituitary cyclic nucleotides and thyrotropin-releasing hormone action: The relationship of adenosine 3’,5’-monophosphate and guanosine 3’,5’-monophosphate to the release of thyrotropin and prolactin, Endocrinology 106: 1304–1310.
Snyder, G., Naor, Z., Fawcett, C. P., and McCann, S. M., 1981, Action of thyrotropin-releasing hormone on mammotrophs and thyrotrophs, Am. J. Physiol. 241: E298 - E304.
Roti, E., Gnudi, A., Robuschi, G., Emanuele, R., Benassi, L., and Braverman, L. E., 1982, Response of growth hormone (GH) to thyrotropinreleasing hormone (TRH) during fetal life, J. Clin. Endocrinol. Metab. 54: 1255–1257.
Snyder, P. J., Muzyka, R., Johnson, J., and Utiger, R. D., 1980, Thyrotropin-releasing hormone provokes abnormal follicle-stimulating hormone (FSH) and luteinizing hormone responses in men who have pituitary adenomas and FSH hypersecretion, J. Clin. Endocrinol. Metab. 51: 744–748.
Faden, A. I., Jacobs, T. P., and Holaday, J. W., 1981, Thyrotropin-releasing hormone improves neurologic recovery after spinal trauma in cats, N. Engl. J. Med. 305: 1063–1067.
Holaday, J. W., D’Amato, R. J., and Faden, A. I., 1981, Thyrotropinreleasing hormone improves cardiovascular function in experimental endotoxic and hemorrhagic shock, Science 213: 216–218.
Parker, D. C., Pekary, A. E., and Hershman, J. M., 1976, Effect of normal and reversed sleep—wake cycles upon nyctohemeral rhythmicity of plasma thyrotropin: Evidence suggestive of an inhibitory influence in sleep, J. Clin. Endocrinol. Metab. 43: 318–329.
Minuto, F., Bagnasco, M., Giusti, M., Grimaldi, G., Biassoni, P., Ferrini, O., and Giordano, G., 1981, Twenty-four hour profile of integrated TSH concentration in puberty, J. Endocrinol. Invest. 4: 7–10.
Spencer, C. A., Greenstadt, M. A., Wheeler, W. S., Kletzky, O. A., and Nicoloff, J. T., 1980, The influence of long-term low dose thyrotropinreleasing hormone infusions on serum thyrotropin and prolactin concentrations in man, J. Clin. Endocrinol. Metab. 51: 771–775.
Hinkle, P. M., Perrone, M. H., and Schonbrunn, A., 1981, Mechanism of thyroid hormone inhibition of thyrotropin-releasing hormone action, Endocrinology 108: 199–205.
Silva, J. E., and Larsen, P. R., 1978, Contributions of plasma triiodothyronine and local thyroxine monodeiodination to triiodothyronine to nuclear triiodothyronine receptor saturation in pituitary, liver, and kidney of hypothyroid rats, J. Clin. Invest. 61: 1247–1259.
Larsen, P. R., Dick, T. E., Markovitz, B. P., Kaplan, M. M., and Gard, T. G., 1979, Inhibition of intrapituitary thyroxine to 3,5,3’-triiodothyronine conversion prevents the acute suppression of thyrotropin release by thyroxine in hypothyroid rats, J. Clin. Invest. 64: 117–128.
Kleinmann, R. E., Vagenakis, A. G., and Braverman, L. E., 1980, The effect of iopanoic acid on the regulation of thyrotropin secretion in eu-thyroid subjects, J. Clin. Endocrinol. Metab. 51: 399–403.
Larsen, P. R., 1982, Feedback regulation of thyrotropin secretion by thyroid hormones, N. Engl. J. Med. 306: 23–32.
Scanlon, F., Chan, V., Heath, M., Pourmand, M., Rodriguez-Arnao, M. D., Weightman, R., Lewis, M., and Hall, R., 1981, Dopamine’ gic control of thyrotropin a-subunit, thyrotropin 3-subunit, and prolactin in euthyroidism and hypothyroidism: Dissociated responses to dopamine receptor blockade with metoclopramide in hypothyroid subjects, J. Clin. Endocrinol. Metab. 53: 360–365.
Feek, C. M., Sawers, J. S. A., Brown, N. S., Seth, J., Irvine, W.J., and Toft, A. D., 1980, Influence of thyroid status on dopaminergic inhibition of thyrotropin and prolactin secretion: Evidence for an additional feedback mechanism in the control of thyroid hormone secretion, J. Clin. Endocrinol. Metab. 51: 585–589.
Pamenter, R. W., and Hedge, G. A., 1980, Inhibition of thyrotropin secretion by physiological levels of corticosterone, Endocrinology 106: 162–166.
Cobb, W. E., Reichlin, S., and Jackson, I. M. D., 1981, Growth hormone secretory status is a determinant of the thyrotropin response to thyrotropinreleasing hormone in euthyroid patients with hypothalamic—pituitary disease, J. Clin. Endocrinol. Metab. 52: 324–329.
Tamagna, E. I., Hershman, J. M., and Jorgensen, E. C., 1979, Thyrotropin suppression by 3,5-dimethyl-3’-isopropyl-t.-thyroxine in man, J. Clin. Endocrinol. Metab. 48: 196–200.
Bech, K., Feldt-Rasmussen, U., and Madsen, S. N., 1981, Influence of thyroglobulin on basal and stimulated human thyroid adenylate cyclase activity, J. Clin. Endocrinol. Metab. 53: 264–269.
Zakarija, M., Witte, A., and McKenzie, J. M., 1980, Influence of cholera toxin on in vitro refractoriness to thyrotropin of thyroids from rats fed propylthiouracil, Endocrinology 107: 2045–2050.
Holmes, S. D., Titus, G., Chou, M., and Field, J. B., 1980, Effects of thyrotropin and cholera toxin on the thyroidal adenylate cyclase—adenosine 3’,5’-monophosphate system, Endocrinology 107: 2076–2081.
Zakarija, M., and McKenzie, J. M., 1980, Influences of cholera toxin on thyroid stimulation by thyrotropin and thyroid-stimulating antibody, Endocrinology 107: 2051–2054.
Engström, G., and Ericson, L. E., 1981, Effect of graded doses of thyrotropin on exocytosis and early phase of endocytosis in the rat thyroid, Endocrinology 108: 399–405.
Ericson, L. E., and Wollman, S. H., 1980, Increase in the rough endoplasmic reticulum in capillary endothelial cells and pericytes in hyperplastic rat thyroid glands, Endocrinology 107: 732–737.
Laurberg, P., 1981, Iodothyronine secretion from perfused dog thyroid lobes after prolonged thyrotropin treatment in vivo, Endocrinology 109: 1560–1565.
Laurberg, P., 1980, Iodothyronine release from the perfused canine thyroid following cessation of stimulation, J. Clin. Invest. 65: 488–495.
Laurberg, P., 1980, Secretion of 3,3’-diiodothyronine by the perfused canine thyroid isolated in situ, Endocrinology 107: 989–993.
Wollman, S. H., and Ekholm, R., 1981, Site of iodination in hyperplastic thyroid glands deduced from autoradiographs, Endocrinology 108: 2082–2085.
Rosenberg, I. N., and Goswami, A., 1979, Purification and characterization of a flavoprotein from bovine thyroid with iodotyrosine deiodinase activity, J. Biol. Chem. 254: 12318–12325.
Hildebrandt, J. D., and Halmi, N. S., 1980, Intrathyroidally generated iodide: The role of propylthiouracil-sensitive processes in its production, Endocrinology 107: 830–838.
Hildebrandt, J. D., and Halmi, N. S., 1981, Intrathyroidally generated iodide: The role of transport in its utilization, Endocrinology 108: 842–849.
Chiraseveenuprapund, P., and Rosenberg, I. N., 1981, Effects of hydrogen peroxide-generating systems on the Wolff-Chaikoff effect, Endocrinology 109: 2095–2101.
Uchimura, H., Chiu, S. C., Kuzaya, N., Ikeda, H., Ito, K., and Nagataki, S., 1980, Effect of iodine enrichment in vitro on the adenylate cyclaseadenosine 3’,5’-monophosphate system in thyroid glands from normal subjects and patients with Graves’ disease, J. Clin. Endocrinol. Metab. 50: 1066–1070.
Sherwin, J. R., and Mills, I., 1980, Epinephrine inhibits thyrotropin-stimulated adenosine 3’,5’-monophosphate accumulation in cat thyroid tissue, Endocrinology 106: 28–34.
Pisarev, M. A., Cardinali, D. P., Juvenal, G. J., Vacas, M. I., Barontini, M., and Boado, R. J., 1981, Role of the sympathetic nervous system in the control of the goitrogenic response in the rat, Endocrinology 109: 2202–2207.
Maayan, M. L., Volpert, E. M., and From, A., 1981, Norepinephrine and thyrotropin effects on the thyroid in vitro: Simultaneous stimulation of iodide organification and antagonism of thyroxine release, Endocrinology 109: 930–934.
Van Sande, J., Dumont, J. E., Melander, A., and Sundler, F., 1980, Presence and influence of cholinergic nerves in the human thyroid, J. Clin. Endocrinol. Metab. 51: 500–502.
Ahren, B., Alumets, J., Ericsson, M., Fahrenkrug, J., Fahrenkrug, L., Hâkanson, R., Hedner, P., Loren, I., Melander, A., Rerup, C., and Sundler, F., 1980, VIP occurs in intrathyroidal nerves and stimulates thyroid hormone secretion, Nature (London) 287: 343–345.
Van Herle, A. J., Vassart, G., and Dumont, J. E., 1979, Control of thyroglobulin synthesis and secretion, N. Engl. J. Med. 301: 307–314.
Scherberg, N. H., Vassart, G., Lecocq, R., Dumont, J. E., and Refetoff, S., 1981, Modulation of thyroglobulin messenger RNA accumulation in the rat thyroid, Endocrinology 109: 1650–1656.
Haeberli, A., Kneubuehl, F., and Studer, H., 1981, Changes in the polypeptide assembly of guinea pig thyroglobulin induced by thyrotropin-regulated thyroid activity, Endocrinology 109: 523–529.
Ikekubo, K., Kishihara, M., Sanders, J., Sutton, J., and Schneider, A. B., 1981, Differences between circulating and tissue thyroglobulin in rats, Endocrinology 109: 427–432.
Unger, J., Van Heuverswyn, B., Decoster, C., Cantraine, F., Mockel, J., and Van Herle, A., 1980, Thyroglobulin and thyroid hormone release after intravenous administration of bovine thyrotropin in man, J. Clin. Endocrinol. Metab. 51: 590–504.
Bayer, M. F., and Kriss, J. P., 1979, Immunoradiometric assay for serum thyroglobulin: Semiquantitative measurement of thyroglobulin in antithyroglobulin-positive sera, J. Clin. Endocrinol. Metab. 49: 557–564.
Mariotti, S., Martino, E., Cupini, C., Lari, R., Giani, C., Baschieri, L., and Pinchera, A., 1982, Low serum thyroglobulin as a clue to the diagnosis of thyrotoxicosis factitia, N. Engl. J. Med. 307: 410–412.
Banerjee, R. K., and Datta, A. G., 1981, Gastric peroxidase—Localization, catalytic properties and possible role in extrathyroidal thyroid hormone formation, Acta Endocrinol. (Copenhagen) 96: 208–214.
Braverman, L. E., Ingbar, S. H., and Sterling, K., 1970, Conversion of thyroxine (T4) to triiodothyronine (T3) in athyreotic human subjects, J. Clin. Invest. 49: 855–864.
Chopra, I. J., 1980, A radioimmunoassay for measurement of 3’-monoiodothyronine, J. Clin. Endocrinol. Metab. 51: 117–123.
Willets, P., Crossley, D. N., Ramsden, D. B., and Hoffenberg, R., 1979, The role of thyronine in thyroid hormone metabolism, J. Clin. Endocrinol. Metab. 49: 658–660.
Faber, J., Busch-Srensen, M., Rogowski, P., Kirkegaard, C., SiersbaekNielsen, K., and Friss, T., 1981, Urinary excretion of free and conjugated 3’,5’-diiodothyronine and 3,3 ’ -diiodothyronine, J. Clin. Endocrinol. Metab. 53: 587–593.
Faber, J., Faber, O. K., Lund, B., Kirkegaard, C., and Wahren, J., 1980, Hepatic extraction and renal production of 3,3’-diiodothyronine and 3’,5’diiodothyronine in man, J. Clin. Invest. 66: 941–945.
McGuire, R. A., and Hays, M. T., 1981, A kinetic model of human thyroid hormones and their conversion products, J. Clin. Endocrinol. Metab. 53: 852–862.
Warren, D. W., LoPresti, J. S., and Nicoloff, J. T., 1981, A new method for measurement of the conversion ration of thyroxine to triiodothyronine in eu thyroid man, J. Clin. Endocrinol. Metab. 53: 1218–1222.
Pardridge, W. M., 1981, Transport of protein-bound hormones into tissues in vivo, Endocr. Rev. 2: 103–123.
Pardridge, W. M., and Mietus, L. J., 1980, Influx of thyroid hormones into rat liver in vivo—differential availability of thyroxine and triiodothyronine bound by plasma proteins, J. Clin. Invest. 66: 367–374.
Yoshida, K., and Davis, P. J., 1980, Estimation of intracellular free triiodothyronine in man, J. Clin. Endocrinol. Metab. 50: 667–669.
Felicetta, J. V., Green, W. L., and Nelp, W. B., 1980, Inhibition of hepatic binding of thyroxine by cholecystographic agents, J. Clin. Invest. 65: 1032–1040.
Acheson, K. J., and Burger, A. G., 1980, A study of the relationship between thermogenesis and thyroid hormones, J. Clin. Endocrinol. Metab. 51: 84–89.
Emrich, D., and Weinheimer, B. (eds.), 1980, Thyroid 1979, J. Mol. Med. 4:3–258, 1980.
Melmed, S., Nademanee, K., Reed, A. W., Hendrickson, J. A., Singh, B. N., and Hershman, J. M., 1981, Hyperthyroxinemia with bradycardia and normal thyrotropin secretion after chronic amiodarone administration, J. Clin. Endocrinol. Metab. 53: 997–1001.
Chopra, I. J., Solomon, D. H., Teco, G. N. C., and Nguyen, A. H., 1980, Inhibition of hepatic outer ring monodeiodination of thyroxine and 3,3’,5’-triiodothyronine by sodium salicylate, Endocrinology 106: 1728–1734.
Greeley, G. H., Jr., Jahnke, G., Nicholson, G. F., and Kizer, J. S., 1980, Decreased serum 3,5,3’-triiodothyronine and thyroxine levels accompanying acute and chronic ritalin treatment of developing rats, Endocrinology 106: 898–904.
Cavalieri, R. R., and Pitt-Rivers, R., 1981, The effects of drugs on the distribution and metabolism of thyroid hormones, Pharm. Rev. 33: 55–80.
Chopra, I. J., Solomon, D. H., Teco, G. N. C., and Eisenberg, J. B., 1982, An inhibitor of the binding of thyroid hormones to serum proteins is present in extrathyroidal tissues, Science 215: 407–409.
Kaptein, E. M., Spencer, C. A., Kamiel, M. B., and Nicoloff, J. T., 1980, Prolonged dopamine administration and thyroid hormone economy in normal and critically ill subjects, J. Clin. Endocrinol. Metab. 51: 387–393.
Slag, M. F., Morley, J. E., Elson, M. K., Crowson, T. W., Nuttall, F. Q., and Shafer, R. B., 1981, Hypothyroxinemia in critically ill patients as a predictor of high mortality, J. Am. Med. Assoc. 245: 43–45.
Kaptein, E. M., Grieb, D. A., Spencer, C. A., Wheeler, W. S., and Nicoloff, J. T., 1981, Thyroxine metabolism in the low thyroxine state of critical nonthyroidal illnesses, J. Clin. Endocrinol. Metab. 53: 764–771.
Pardridge, W. M., Slag, M. F., Morley, J. E., Elson, M. K., Shafer, R. B., and Mietus, L. J., 1981, Hepatic bioavailability of serum thyroid hormones in nonthyroidal illness, J. Clin. Endocrinol. Metab. 53: 913–916.
Geola, F. L., Chopra, I. J., and Geffner, D. L., 1980, Patterns of 3,3’,5’triiodothyronine monodeiodination in hypothyroidism and nonthyroid illnesses, J. Clin. Endocrinol. Metab. 50: 336–340.
Braverman, L. E., Abreau, C. M., Brock, P., Kleinmann, R., Fournier, L., Odstrchel, G., and Schoemaker, H. J. P., 1980, Measurement of serum free thyroxine by RIA in various clinical states, J. Nucl. Med. 21: 233–239.
Chopra, I. J., Van Herle, A. J., Teco, G. N. C., and Nguyen, A. H., 1980, Serum free thyroxine in thyroidal and nonthyroidal illnesses: A comparison of measurements by radioimmunoassay, equilibrium dialysis, and free thyroxine index, J. Clin. Endocrinol. Metab. 51: 135–143.
Bayer, M. F., and McDougall, I. R., 1980, Radioimmunoassay of free thyroxine in serum: Comparison with clinical findings and results of conventional thyroid-function tests, Clin. Chem. 26: 1186–1192.
Kaptein, E. M., Maclntyre, S. S., Weiner, J. M., Spencer, C. A., and Nicoloff, J. T., 1981, Free thyroxine estimates in nonthyroidal illness: Comparison of eight methods, J. Clin. Endocrinol. Metab. 52: 1073–1077.
Melmed, S., Geola, F. L., Reed, A. W., Pekary, A. E., Park, J., and Hershman, J. M., 1982, A comparison of methods for assessing thyroid function in nonthyroidal illness, J. Clin. Endocrinol. Metab. 54: 300–306.
Boss, A. M. B., and Kingstone, D., 1981, Further observations on serum free thyroxine concentrations during pregnancy, Br. Med. J. 283: 584.
Slag, M. F., Morley, J. E., Elson, M. K., Labrosse, K. R., Crowson, T. W., Nuttall, F. Q., and Shafer, R. B., 1981, Free thyroxine levels in critically ill patients-A comparison of currently available assays, J. Am. Med. Assoc. 246: 2702–2706.
Kaplan, M. M., Larsen, P. R., Crantz, F. R., Dzau, V. J., Rossing, T. H., and Haddow, J. E., 1982, Prevalence of abnormal thyroid function test results in patients with acute medical illnesses, Am. J. Med. 72: 9–16.
Gavin, L. A., Rosenthal, M., and Cavalieri, R. R., 1979, The diagnostic dilemma of isolated hyperthyroxinemia in acute illness, J. Am. Med. Assoc. 242: 251–253.
Cohen, K. L., and Swigar, M. E., 1979, Thyroid function screening in psychiatric patients, J. Am. Med. Assoc. 242: 254–257.
Levy, R. P., Jensen, J. B., Laus, V. G., Agle, D. P., and Engel, I. M., 1981, Serum thyroid hormone abnormalities in psychiatric disease, Metabolism 30: 1060–1064.
Pont, A., Spratt, D. I., McDougall, I. R., Miller, M. B., McLaughlin, W. T., and Bayer, M. F., 1981, Hyperthyroxinemia in acute psychiatric patients, Program of the American Thyroid Association, 57th Annual Meeting, p. T-4.
Gardner, D. F., Carithers, R. L., Jr., and Utiger, R. D., 1982, Thyroid function tests in patients with acute and resolved hepatitis B virus infection, Ann. Intern. Med. 96: 450–452.
Faber, J., Thomsen, H. F., Lumholtz, I. B., Kirkegaard, C., SiersbaekNielsen, K., and Friss, T., 1981, Kinetic studies of thyroxine, 3,5,3’-triiodothyronine, 3,3’,5’-triiodothyronine, 3’,5’-diiodothyronine, 3,3’-diiodothyronine, and 3’-monoiodothyronine in patients with liver cirrhosis, J. Clin. Endocrinol. Metab. 53: 978–984.
Afrasiabi, M. A., Vaziri, N. D., Gwinup, G., Mays, D. M., Barton, C. H., Ness, R. L., and Valenta, L. J., 1979, Thyroid function studies in the nephrotic syndrome, Ann. Intern. Med. 90: 335–338.
Felicetta, J. V., Green, W. L., Haas, L. B., Kenny, M. A., Sherrard, D. J., and Brunzell, J. D., 1979, Thyroid function and lipids in patients with chronic renal disease treated by hemodialysis: With comments on the “free thyroxine index,” Metabolism 28: 756–763.
Lim, V. S., Henriquez, C., Seo, H., Refetoff, S., and Martino, E., 1980, Thyroid function in a uremic rat model—Evidence suggesting tissue hypothyroidism, J. Clin. Invest. 66: 946–954.
Thompson, P., Jr., Burman, K. D., Lukes, Y. G., McNeil, J. S., Jackson, B. D., Latham, K. R., and Wartofsky, L., 1980, Uremia decreases nuclear 3,5,3’-triiodothyronine receptors in rats, Endocrinology 107: 1081–1084.
Fujii, S., Akai, T., Tanaka, S., Nakatani, K., Kinoshita, M., Seki, J., and Wada, M., 1981, Thyroid hormone abnormalities in patients with diabetes mellitus, J. Endocrinol. Invest. 4: 71–74.
Mayfield, R. K., Sagel, J., and Colwell, J. A., 1980, Thyrotoxicosis without elevated serum triiodothyronine levels during diabetic ketoacidosis, Arch. Intern. Med. 140: 408–410.
Ahmad, N., and Cohen, M. P., 1981, Thyroid storm with normal serum triiodothyronine level during diabetic ketoacidosis, J. Am. Med. Assoc. 245: 2516–2517.
Gonzalez, C., Montoya, E., Jolin, T., and Gonzalez, M., 1980, Effect of streptozotocin diabetes on the hypothalamic-pituitary-thyroid axis in the rat, Endocrinology 107: 2099–2103.
Bagchi, N., Brown, T. R., Shivers, B., Lucas, S., and Mack, R. E., 1981, Decreased thyroidal response to thyrotropin in diabetic mice, Endocrinology 109: 1428–1432.
Wiersinga, W. M., Frank, H. J. L., Chopra, I. J., and Solomon, D. H., 1982, Alterations in hepatic nuclear binding of triiodothyronine in experimental diabetes mellitus in rats, Acta Endocrinol. (Copenhagen) 99: 79–85.
Las, M. S., and Surks, M. L., 1981, Dissociation of serum triiodothyronine concentration and hepatic nuclear triiodothyronine-binding capacity in streptozotocin-induced diabetic rats, Endocrinology 109: 1259–1263.
Das, D. K., and Ganguly, M., 1981, Diabetes, hypophysectomy, or thyroidectomy reduces nuclear L-triiodothyronine-binding capacity of rat lung, Endocrinology 109: 296–300.
Maturlo, S. J., Rosenbaum, R. L., Pan, C., and Surks, M. I., 1980, Variable thyrotropin response to thyrotropin-releasing hormone after small decreases in plasma free thyroid hormone concentrations in patients with nonthyroidal diseases, J. Clin. Invest. 66: 451–456.
Wood, D. G., and Samols, E., 1982, Impaired thyroid stimulating hormone secretion with decreased free T4 in nonthyroidal illness, Clin. Res. 30: 494A.
Kumara-Siri, M. H., Lee, K., and Surks, M. I., 1981, Regulation of thyrotropin secretion in rats bearing the Walker 256 carcinoma, Endocrinology 109: 1760–1768.
Eisenstein, Z., Balsom, A., Garber, J. R., and Ingbar, S. H., 1980, A study of the properties of the enzyme in rat liver that deiodinates 3,3’,5’-triiodothyronine to 3,3’-diiodothyronine, Endocrinology 107: 530–537.
Heinen, E., Basler, M., Herrmann, J., Hafner, D., and Krüskemper, H. L., 1980, Enzyme kinetic and substrate-binding studies of the thyroxine to 3,5,3’-triiodothyronine converting enzyme in the rat liver microsomal fraction, Endocrinology 107: 1198–1204.
Chopra, I. J., 1981, Characteristics of outer ring (5’- or 3’-) monodeiodination of 3’,5’- and 3,3’-diiodothyronine: Evidence suggesting one outer ring monodeiodinase for various iodothyronines, Endocrinology 108: 464–471.
Visser, T. J., Leonard, J. L., Kaplan, M. M., and Larsen, P. R., 1982, Molecular mechanisms of thyroid hormone 5’-deiodination in rat brain and pituitary, 64th Annual Meeting of the Endocrine Society, p. 132.
Maeda, M., and Ingbar, S. H., 1982, Evidence that the 5’-monodeiodinases for thyroxine (T4) and for 3,3’,5’-triiodothyronine (reverse T3, rT3) are separate enzymes, 64th Annual Meeting of the Endocrine Society, p. 133.
dem Brinke, D. A., Köhrle, J., Ködding, R., and Hesch, R.-D., 1980, Sub-cellular localization of thyroxine-5-deiodinase in rat liver, J. Endocrinol. Invest. 3: 73–76.
Cavalieri, R. R., Gavin, L. A., and Bui, F., 1977, Conversion of thyroxine to 3,3’,5’-triiodothyronine (reverse-T3) by a soluble enzyme system of rat liver, Biochem. Biophys. Res. Commun. 79: 897–902.
Fekkes, D., Overmeeren-Kaptein, E. V., Docter, R., Hennemann, G., and Visser, T. J., 1979, Location of rat liver iodothyronine deiodinating enzymes in the endoplasmic reticulum, Biochim. Biophys. Acta 587: 12–19.
Maciel, R. M. B., Ozawa, Y., and Chopra, I.J., 1979, Subcellular localization of thyroxine and reverse triiodothyronine outer ring monodeiodinating activities, Endocrinol. 104: 365–370.
Takaishi, M., Shimizu, T., and Shishiba, Y., 1979, Solubilization of thyroxine-5’-deiodinase activity from rat liver microsome fraction, Acta Endocrinol. (Copenhagen) 92: 694–701.
Fekkes, D., Overmeeren, E. V., Hennemann, G., and Visser, T. J., 1980, Solubilization and partial characterization of rat liver iodothyronine deiodinases, Biochim. Biophys. Acta 613: 41–51.
Leonard, J. L., and Rosenberg, I. N., 1980, lodothyronine 5’-deiodinase from rat kidney: Substrate specificity and the 5’-deiodination of reverse triiodothyronine, Endocrinology 107: 1376–1383.
Kaplan, M. M., 1980, Thyroxine 5’-monodeiodination in rat anterior pituitary homogenates, Endocrinology 106: 567–576.
Crantz, F. R., and Larsen, P. R., 1980, Rapid thyroxine to 3,5,3’-triiodothyronine conversion and nuclear 3,5,3’-triiodothyronine binding in rat cerebral cortex and cerebellum, J. Clin. Invest. 65: 935–938.
Kaplan, M. M., McCann, U. D., Yaskoski, K. A., Larsen, P. R., and Leonard, J. L., 1981, Anatomical distribution of phenolic and tyrosyl ring iodothyronine deiodinases in the nervous system of normal and hypothyroid rats, Endocrinology 109: 397–402.
Tanaka, K., Inada, M., Ishii, H., Naito, K., Nishikawa, M., Mashio, Y., and Imura, H., 1981, Inner ring monodeiodination of thyroxine and 3,5,3’-Ltriiodothyronine in rat brain, Endocrinology 109: 1619–1624.
Leonard, J. L., Kaplan, M. M., Visser, T. J., Silva, J. E., and Larsen, P. R., 1981, Cerebral cortex responds rapidly to thyroid hormones, Science 214: 571–573.
Nishikawa, M., Inada, M., Naito, K., Ishii, H., Tanaka, K., Mashio, Y., Nakao, K., Nakai, Y., Udaka, F., and Imura, H., 1981, 3,3’,5’-triiodothyronine (reverse T3) in human cerebrospinal fluid, J. Clin. Endocrinol. Metab. 53: 1030–1035.
Melmed, S., Nelson, M., Kaplowitz, N., Yamada, T., and Hershman, J. M., 1981, Glutathione-dependent thyroxine 5’-monodeiodination modulates growth hormone production by cultured nonthyrotropic rat pituitary cells, Endocrinology 108: 970–976.
Roti, E., Fang, S. L., Green, K., Emerson, C. H., and Braverman, L. E., 1981, Human placenta is an active site of thyroxine and 3,3’,5-triiodothyronine tyrosyl ring deiodination, J. Clin. Endocrinol. Metab. 53: 498–501.
Roti, E., Fang, S. L., Braverman, L. E., and Emerson, C. H., 1982, Rat placenta is an active site of inner ring deiodination of thyroxine and 3,3’,5triiodothyronine, Endocrinology 110: 34–37.
Roti, E., Fang, S. L., Green, K., Braverman, L. E., and Emerson, C. H., 1983, Inner ring deiodination of thyroxine and 3,3’,5-triiodothyronine by human fetal membranes, Am. J. Obstet. Gynecol. 147: 788–792.
El-Zaheri, M., Vagenakis, A. G., Hinerfeld, L., Emerson, C. H., and Braverman, L. E., 1981, Maternal thyroid function is the major determinant of amniotic fluid reverse T3 in the rat, J. Clin. Invest. 67: 1126–1133.
Erickson, V. J., Cavalieri, R. R., and Rosenberg, L. L., 1981, Phenolic and nonphenolic ring iodothyronine deiodinases from rat thyroid gland, Endocrinology 108: 1257–1264.
Ishii H., Inada, M., Tanaka, K., Mashio, Y., Natto, K., Nishikawa, M., and Imura, H., 1981, Triiodothyronine generation from thyroxine in human thyroid: Enhanced conversion in Graves’ thyroid tissue, J. Clin. Endocrinol. Metab. 52: 1211–1217.
Borges, M., Eisenstein, Z., Burger, A. G., and Ingbar, S. H., 1981, Immunsequestration: A new technique for studying peripheral iodothyronine metabolism in vitro, Endocrinology 108: 1665–1671.
Pittman, C. S., Shimizu, T., Burger, A., and Chambers, J. B., Jr., 1980, The nondeiodinative pathways of thyroxine metabolism: 3,5,3’,5’-tetraiodothyroacetic acid turnover in normal and fasting human subjects, J. Clin. Endocrinol. Metab. 50: 712–716.
Gavin, L. A., Bui, F., McMahon, F., and Cavalieri, R. R., 1980, Sequential deiodination of thyroxine to 3,3’-diiodothyronine via 3,5,3’-triiodothyronine and 3,3’,5’-triiodothyronine in rat liver homogenate, J. Biol. Chem. 254: 49–53.
Gavin, L. A., McMahon, F. A., and Moeller, M., 1981, Dietary modification of thyroxine deiodination in liver is not mediated by hepatic sulfhydryls, J. Clin. Invest. 65: 943–946.
Harris, A. R., Fang, S. L., Hinerfeld, L., Braverman, L. E., and Vagenakis, A. G., 1979, The role of sulfhydryl groups on the impaired hepatic 3’,3,5triiodothyronine generation from thyroxine in the hypothyroid, starved, fetal, and neonatal rodent, J. Clin. Invest. 63: 516–524.
Balsam, A., Ingbar, S. H., and Sexton, F., 1979, Observations on the factors that control the generation of triiodothyronine from thyroxine in rat liver and the nature of the defect induced by fasting, J. Clin. Invest. 63: 1145–1156.
Kaplan, M. M., 1979, Subcellular alterations causing reduced hepatic thyroxine-5’-monodeiodinase activity in fasted rats, Endocrinology 104: 58–64.
Chopra, I. J., 1980, Alterations in monodeiodination of iodothyronines in the fasting rat: Effects of reduced nonprotein sulfhydryl groups and hypothyroidism, Metabolism 29: 161–167.
Gavin, L. A., McMahon, F. A., and Moeller, M., 1981, Carbohydrate in contrast to protein feeding increases the hepatic content of active thyroxine-5’-deiodinase in the rat, Endocrinology 109: 530–536.
Sato, K., and Robbins, J., 1981, Thyroid hormone metabolism in primary cultured rat hepatocytes, J. Clin. Invest. 68: 475–483.
Senga, O., Pittman, C. S., Lindsay, R. H., Chambers, J. B., Jr., and Hill, J. B., Jr., 1982, Comparison of the peripheral thyroid hormone metabolism in normal rats and in rats receiving prolonged glucagon infusion, Endocrinology 110: 2011–2017.
Sorimachi, K., and Robbins, J., 1978, Thyroxine inactivation by starvation in cultured hepatocarcinoma cells: Formation of reverse triiodothyronine, Norm. Metab. Res. 10: 459–575.
Sato, K., and Robbins, J., 1981, Glutathione deficiency induced by cystine and/or methionine deprivation does not affect thyroid hormone deiodination in cultured rat hepatocytes and monkey hepatocarcinoma cells, Endocrinology 109: 844–852.
Takai, N. A., Rapoport, B., and Yamamoto, M., 1980, Biliary excretion of iodothyronines in rats as determined by high pressure liquid chromatography: Effect of starvation, Endocrinology 107: 176–182.
Balsam, A., Sexton, F., and Ingbar, S. H., 1981, The influence of fasting and the thyroid state on the activity of thyroxine 5’-monodeiodinase in rat liver: a kinetic analysis of microsomal formation of triiodothyronine from thyroxine, Endocrinology 108: 472–477.
Burger, A. G., Weissel, M., and Berger, M., 1980, Starvation induces a partial failure of triiodothyronine to inhibit the thyrotropin response to thyrotropin-releasing hormone, J. Clin. Endocrinol. Metab. 51: 1064–1067.
Gardner, D. F., Kaplan, M. M., Stanley, C. A., and Utiger, R. D., 1979, Effect of tri-iodothyronine replacement on the metabolic and pituitary responses to starvation, N. Engl. J. Med. 300: 579–584.
Schwartz, H. L., Lancer, S. R., and Oppenheimer, J. H., 1980, Thyroid hormones influence starvation-induced hepatic protein loss in the rat: Possible role of thyroid hormones in the generation of labile protein, Endocrinology 107: 1684–1692.
Oppenheimer, J. H., and Schwartz, H. L., 1980, Factors determining the level of activity of 3,5,3’-triiodothyronine-responsive hepatic enzymes in the starved rat, Endocrinology 107: 1460–1468.
Mariash, C. N., Kaiser, F. E., Schwartz, H. L., Towle, H. C., and Oppenheimer, J. H., 1980, Synergism of thyroid hormone and high carbohydrate diet in the induction of lipogenic enzymes in the rat, J. Clin. Invest. 67: 1126–1134.
Forciea, M. A., Schwartz, H. L., Towle, H. C., Mariash, C. N., Kaiser, F. E., and Oppenheimer, J. H., 1981, Thyroid hormone-carbohydrate interaction in the rat, J. Clin. Invest. 67: 1739–1747.
Mariash, C. N., McSwigan, C. R., Towle, H. C., Schwartz, H. L., and Oppenheimer, J. H., 1981, Glucose and triiodothyronine both induce malic enzyme in the rat hepatocyte culture, J. Clin. Invest. 68: 1485–1490.
Simat, B. M., Towle, H. C., Schwartz, H. L., and Oppenheimer, J. H., 1980, Difference between thyroidectomized and hypophysectomized animals in their hepatic ribonucleic acid response to thyroid hormone, Endocrinology 107: 1338–1344.
Walker, P., Weichsel, M. E., Jr., Hoath, S. B., Poland, R. E., and Fisher, D. A., 1981, Effect of thyroxine, testosterone, and corticosterone on nerve growth factor (NGF) and epidermal growth factor (EGF) concentrations in adult female mouse submaxillary gland: Dissociation of NGF and EGF responses, Endocrinology 109: 582–587.
Gambert, S. R., Ingbar, S. H., and Hagen, T. C., 1981, Interaction of age and thyroid hormone status on Nat-K+ ATPase in rat renal cortex and liver, Endocrinology 108: 27–30.
Dratman, M. B., Futaesaku, Y., Crutchfield, F. L., Berman, N., Payne, B., Sar, M., and Stumpf, W. E., 1982, Iodine-125-labeled triiodothyronine in rat brain: Evidence for localization in discrete neural systems, Science 215: 309–312.
Kriz, B. M., Fong, B. B., and Goldfine, I. D., 1981, Quantitative electron microscope autoradiographs of 125I-L-triiodothyronine: Evidence for multiple sites of hormone localization, Clin. Res. 29: 506A.
Sterling, K., 1979, Thyroid hormone action at the cell level, N. Engl. J. Med. 300: 117–124, 173–177.
Segal, J., and Ingbar, S. H., 1980, Direct and synergistic interactions of 3,5,3’-triiodothyronine and the adrenergic system in stimulating sugar transport by rat thymocytes, J. Clin. Invest. 65: 958–966.
Maxfield, F. R., Willingham, M. C., Pastan, I., Dragsten, P., and Cheng, S.-Y., 1981, Binding and mobility of the cell surface receptors for 3,3’,5triiodo-L-thyronine, Science 211: 63–64.
Young, R. A., Braverman, L. E., and Rajatanavin, R., 1982, Low protein-high carbohydrate diet induces alterations in the serum thyronine binding proteins in the rat, Endocrinology 110: 1607–1612.
Smallridge, R. C., Glass, A. R., Wartofsky, L., Ward, K. G., and Burman, K. D., 1980, Investigations into the etiology of elevated serum triiodothyronine (T3) levels in protein malnourished rats, 62nd Annual Meeting of the Endocrine Society, p. 223.
Okamura, K., Taurog, A., and Krulich, L., 1981, Elevation of serum 3,5,3’triiodothyronine and thyroxine levels in rats fed Remington diets: Opposing effects of nutritional deficiency and iodine deficiency, Endocrinology 108: 1247–1256.
Okamura, K., Taurog, A., and DiStefano, J. J., III, 1981, Elevated serum levels of T3 without metabolic effect in nutritionally deficient rats, attributable to reduced cellular uptake of T3, Endocrinology 109: 673–675.
Hennemann, G., Docter, R., Krenning, E. P., Bos, G., Otten, M., and Visser, T. J., 1979, Raised total thyroxine and free thyroxine index but normal free thyroxine: A serum abnormality due to inherited increased affinity of iodothyronines for serum binding protein, Lancet 1: 639–642.
Lee, W. N. P., Golden, M. P., van Herle, A. J., Lippe, B. M., and Kaplan, S. A., 1979, Inherited abnormal thyroid hormone-binding protein causing selective increase of total serum thyroxine, J. Clin. Endocrinol. Metab. 49: 292–299.
Stockigt, J. R., Topliss, D. J., Barlow, J. W., White, E. L., Hurley, D. M., and Taft, P., 1981, Familial euthyroid thyroxine excess: An appropriate response to abnormal thyroxine binding associated with albumin, J. Clin. Endocrinol. Metab. 53: 353–359.
Ruiz, M., Rajatanavin, R., Young, R. A., Taylor, C., Brown, R., Braverman, L. E., and Ingbar, S. H., 1982, Familial dysalbuminemic hyperthyroxinemia, N. Engl. J. Med. 306: 635–639.
Moses, A. C., Lawlor, J., Haddow, J., and Jackson, I. M. D., 1982, Familial euthyroid hyperthyroxinemia resulting from increased thyroxine binding to thyroxine-binding prealbumin, N. Engl. J. Med. 306: 966–969.
Morley, J. E., Shafer, R. B., Elson, M. K., Slag, M. F., Raleigh, M. J., Brammer, G. L., Yuwiler, A., and Hershman, J. M., 1980, Amphetamine-induced hyperthyroxinemia, Ann. Intern. Med. 93: 707–709.
Geola, F. L., Hershman, J. M., Reed, A. W., and Premachandra, B. N., 1981, Circulating thyroid hormone autoantibodies in a hypothyroid patient: Effect on thyroxine metabolic clearance rate, J. Clin. Endocrinol. Me-tab. 53: 580–586.
Inada, M., Nishikawa, M., Naito, K., Oishi, M., Kurata, S., and Imura, H., 1980, Triiodothyronine-binding immunoglobulin in a patient with Graves’ disease and its effect on metabolism and radioimmunoassay of triiodothyronine, Am. J. Med. 68: 787–792.
Gärtner, R., Henze, R., Horn, K., Pickardt, C. R., and Scriba, P. C., 1981, Thyroxine-binding globulin: Investigation of microheterogeneity, J. Clin. Endocrinol. Metab. 52: 657–664.
Garnick, M. B., and Larsen, P. R., 1979, Acute deficiency of thyroxine-binding globulin during L-asparaginase therapy, N. Engl. J. Med. 301: 252–253.
Yabu, Y., Amino, N., Nakatani, K., Ichihara, K., Azukizawa, M., and Miyai, K., 1980, Graves’ disease associated with elevated serum thyroxine-binding globulin concentrations, J. Clin. Endocrinol. Metab. 51: 325–329.
Smals, A. G., Ross, A. H., and Kloppenborg, P. W. C., 1981, Dichotomy between serum free triiodothyronine and free thyroxine concentrations in familial thyroxine-binding globulin deficiency, J. Clin. Endocrinol. Metab. 53: 917–922.
Fisher, D. A., and Klein, A. H., 1981, Thyroid development and disorders of thyroid function in the newborn, N. Engl. J. Med. 304: 702–712.
Porterfield, S. P., and Hendrich, C. E., 1981, Alterations of serum thyroxine, triiodothyronine, and thyrotropin in the progeny of hypothyroid rats, Endocrinology 108: 1060–1063.
Coulombe, P., Ruel, J., and Dussault, J. H., 1980, Effects of neonatal hypo-and hyperthyroidism on pituitary growth hormone content in the rat, Endocrinology 107: 2027–2033.
Avivi, A., Shemesh, M., and Lindner, H. R., 1981, The ontogeny of the thyrotropin-thyroid axis in early bovine embryos, Endocrinology 109: 1611–1618.
Oliver, C., Giraud, P., Lissitzky, J. C., Conte-Devolx, B., and Gillioz, P., 1981, Influence of thyrotropin-releasing hormone on the secretion of thyrotropin in neonatal rats, Endocrinology 108: 179–182.
Theodoropoulos, T., Braverman, L. E., and Vagenakis, A. G., 1979, Thyrotropin-releasing hormone is not required for thyrotropin secretion in the perinatal rat, J. Clin. Invest. 63: 588–594.
Tonooka, N., and Greer, M. A., 1978, Evidence that control of fetal thyrotropin secretion is independent of both the fetal and maternal hypothalamus, Endocrinology 102: 852–858.
Frankel, S., and Lange, G., 1980, Maturation of hypothalamic-pituitary-thyroid response in the rat to acute cold, Am. J. Physiol. Endocrinol. Metab. 2: E223 - E226.
Walker, P., Coulombe, P., and Dussault, J. H., 1980, Effects of triiodothyronine on thyrotropin-releasing hormone-induced thyrotropin release in the neonatal rat, Endocrinology 107: 1731–1737.
Klein, A. H., and Fisher, D. A., 1980, Thyrotropin-releasing hormone-stimulated pituitary and thyroid gland responsiveness and 3,5,3’-triiodothyronine suppression in fetal and neonatal lambs, Endocrinology 106: 697–701.
Roti, E., Gnudi, A., Braverman, L. E., Robuschi, G., Emanuele, R., Bandini, P., Benassi, L., Pagliani, A., and Emerson, C. H., 1981, Human cord blood concentrations of thyrotropin, thyroglobulin, and iodothyronines after maternal administrations of thyrotropin-releasing hormone, J. Clin. Endocrinol. Metab. 53: 813–817.
Pezzino, V., Filetti, S., Belfiore, A., Proto, S., Donzelli, G., and Vigneri, R., 1981, Serum thyroglobulin levels in the newborn, J. Clin. Endocrinol. Metab. 52: 364–366.
Ket, J. L., de Vijlder, J. J. M., Bikker, H., Gons, M. H., and Tegelaers, W. H. H., 1981, Serum thyroglobulin levels: The physiological decrease in infancy and the absence in athyroidism, J. Clin. Endocrinol. Metab. 53: 1301–1303.
Tenore, A., Parks, J. S., Gasparo, M., and Koldovsky, O., 1980, Thyroidal response to peroral TSH in suckling and weaned rats, Am. J. Physiol. Endocrinol. Metab. 1: E428 — E430.
Borges, M., LaBourene, J., and Ingbar, S. H., 1980, Changes in hepatic iodothyronine metabolism during ontogeny of the chick embryo, Endocrinology 107: 1751–1761.
Galton, V. A., and Munck, K., 1981, Metabolism of thyroxine in Rana catesbeiana tadpoles during metamorphic climax, Endocrinology 109: 1127–1131.
Galton, V. A., 1980, Binding of thyroid hormones in vivo by hepatic nuclei of Rana catesbeiana tadpoles at different stages of metamorphosis, Endocrinology 107: 1910–1915.
Galton, V. A., and Cohen, J. S., 1980, Action of thyroid hormones in premetamorphic tadpoles: An important role of thyroxine?, Endocrinology 107: 1820–1826.
Gonzales, L. W., and Ballard, P. L., 1981, Identification and characterization of nuclear 3,5,3’-triiodothyronine-binding sites in fetal human lung, J. Clin. Endocrinol. Metab. 53: 21–28.
Hitchcock, K. R., Harney, J., and Reichlin, S., 1980, Hormones and the lung. III. Thyroid hormone uptake kinetics of perinatal rat lung, Endocrinology 107: 294–299.
Ballard, P. L., Benson, B. J., Brehier, A., Carter, J. P., Kriz, B. M., and Jorgensen, E. C., 1980, Transplacental stimulation of lung development in the fetal rabbit by 3,5-dimethyl-3’-isopropyl-L-thyroxine, J. Clin. Invest. 65: 1407–1417.
Matsuura, N., Yamada, Y., Nohara, Y., Konishi, J., Kasagi, K., Endo, K., Kojima, H., and Wataya, K., 1980, Familial neonatal transient hypothyroidism due to maternal TSH-binding inhibitor immunoglobulins, N. Engl. J. Med. 303: 738–741.
Czernichow, P., Vandalem, J. L., and Hennen, G., 1981, Transient neonatal hyperthyrotropinemia: A factitious syndrome due to the presence of heterophilic antibodies in the plasma of infants and their mothers, J. Clin. Endocrinol. Metab. 53: 387–393.
Gendrel, D., Feinstein, M.-C., Grenier, J., Roger, M., Ingrand, J., Chaussain, J.-L., Canlorbe, P., and Job, J.-B., 1981, Falsely elevated serum thyrotropin (TSH) in newborn infants: Transfer from mothers to infants of a factor interfering in the TSH radioimmunoassay, J. Clin. Endocrinol. Metab. 52: 62–65.
Sugenoya, A., Kidd, A., Row, V. V., and Volpe, R., 1979, Correlation between thyrotropin-displacing activity and human thyroid-stimulating activity by immunoglobulins from patients with Graves’ disease and other thyroid disorders, J. Clin. Endocrinol. Metab. 48: 398–402.
Kuzuya, N., Chiu, S. C., Ikeda, H., Uchimura, H., Ito, K., and Nagataki, S., 1979, Correlation between thyroid stimulators and 3,5,3’-triiodothyronine suppressibility in patients during treatment for hyperthyroidism with thionamide drugs: Comparison of assays by thyroid-stimulating and thyrotropin-displacing activities, J. Clin. Endocrinol. Metab. 48: 706–711.
Endo, K., Amir, S. M., and Ingbar, S. H., 1981, Development and evaluation of a method for the partial purification of immunoglobulins specific for Graves’ disease, J. Clin. Endocrinol. Metab. 52: 1113–1123.
Kishihara, M., Nakao, Y., Baba, Y., Kobayashi, N., Matsukura, S., Kuma, K., and Fujita, T., 1981, Interaction between thyrotropin (TSH) binding inhibitor immunoglobulins (TBII) and soluble TSH receptors in fat cells, J. Clin. Endocrinol. Metab. 52: 665–670.
Davies, T. F., 1981, Autoantibodies to the human thyrotropin receptor are not species specific, J. Clin. Endocrinol. Metab. 52: 426–430.
Ealey, P. A., Marshall, N. J., and Ekins, R. P., 1981, Time-related thyroid stimulation by thyrotropin and thyroid-stimulating antibodies, as measured by the cytochemical section bioassay, J. Clin. Endocrinol. Metab. 52: 483–487.
Loveridge, N., Zakarija, M., Bitensky, L., and McKenzie, J. M., 1979, The cytochemical bioassay for thyroid-stimulating antibody of Graves’ disease: Further experience, J. Clin. Endocrinol. Metab. 49: 610–615.
Hinds, W. E., Takai, N., Rapoport, B., Filetti, S., and Clark, O. H., 1981, Thyroid-stimulating immunoglobulin bioassay using cultured human thyroid cells, J. Clin. Endocrinol. Metab. 52: 1204–1210.
Stöcke, G., Wahl, R., and Seif, F. J., 1981, Micromethod of human thyrocyte cultures for detection of thyroid-stimulating antibodies and thyrotropin, Acta Endocrinol. (Copenhagen) 97: 369–375.
Bidey, S. P., Marshall, N. J., and Ekins, R. P., 1981, Adenylate cyclase activity and the accumulation and release of adenosine 3’,5’-monophosphate in normal human thyroid tissue slice preparations: Responses to thyrotropin and thyroid-stimulating antibodies, J. Clin. Endocrinol. Metab. 53: 246–253.
Atkinson, S., and Kendall-Taylor, P., 1981, The stimulation of thyroid hormone secretion in vitro by thyroid-stimulating antibodies, J. Clin. Endocrinol. Metab. 53: 1263–1266.
Ozawa, Y., Maciel, R. M. B., Chopra, I. J., Solomon, D. H., and Beall, G. N., 1979, Relationships among immunoglobulin markers in Graves’ disease, J. Clin. Endocrinol. Metab. 48: 381–387.
Kasagi, K., Konishi, J., Endo, K., Mori, T., Nagahara, K., Makimoto, K., Kuma, K., and Torizuka, K., 1980, Adenylate cyclase activity in thyroid tissue from patients with untreated Graves’ disease, J. Clin. Endocrinol. Metab. 51: 492–499.
Kuzuya, N., Uchimura, H., Ikeda, H., Chiu, S. C., Hamada, N., Ito, K., and Nagataki, S., 1980, Adenosine 3’,5’-monophosphate concentrations and responsiveness to thyrotropin and thyroid-stimulating immunoglob- ulins in normal and Graves’ thyroids, J. Clin. Endocrinol. Metab. 51: 59–63.
Drexhage, H. A., Bottazzo, G. F., Doniach, D., Bitensky, L., and Chayen, J., 1980, Evidence for thyroid-growth-stimulating immunoglobulins in some goitrous thyroid diseases, Lancet 2: 287–292.
Takata, I., Suzuki, Y., Saida, K., and Sato, T., 1980, Human thyroid stimulating activity and clinical state in antithyroid treatment of juvenile Graves’ disease, Acta Endocrinol. (Copenhagen) 94: 46–52.
Fenzi, G., Hashizume, K., Roudebush, C. P., and DeGroot, L. J., 1979, Changes in thyroid-stimulating immunoglobulins during antithyroid therapy, J. Clin. Endocrinol. Metab. 48: 572–576.
Teng, C. S., and Yeung, R. T. T., 1980, Changes in thyroid-stimulating antibody activity in Graves’ disease treated with antithyroid drug and its relationship to relapse: A prospective study, J. Clin. Endocrinol. Metab. 50: 144–147.
McGregor, A. M., Smith, B. R., Hall, R., Petersen, M. M., Miller, M., and Dewar, P. J., 1980, Prediction of relapse in hyperthyroid Graves’ disease, Lancet 1: 1101–1103.
Zakarija, M., McKenzie, J. M., and Banovac, K., 1980, Clinical significance of assay of thyroid-stimulating antibody in Graves’ disease, Ann. Intern. Med. 93: 28–32.
Karlsson, F. A., and Dahlberg, P. A., 1981, Thyroid stimulating antibodies (TSAb) in patients with Graves’ disease undergoing antithyroid drug treatment: Indicators of activity of disease, Clin. Endocrinol. 14: 579–585.
McGregor, A. M., Petersen, M. M., McLachlan, S. M., Rooke, P., Smith, B. R., and Hall, R., 1980, Carbimazole and the autoimmune response in Graves’ disease, N. Engl. J. Med. 303: 302–307.
McGregor, A. M., Ibbertson, H. K., Smith, B. R., and Hall, R., 1980, Carbimazole and autoantibody synthesis in Hashimoto’s thyroiditis, Br. Med. J. 281: 968–969.
Hallengren, B., Forsgren, A., and Melander, A., 1980, Effects of antithyroid drugs on lymphocyte function in vitro, J. Clin. Endocrinol. Metab. 51: 298–301.
Weiss, I., and Davies, T. F., 1981, Inhibition of immunoglobulin-secreting cells by antithyroid drugs, J. Clin. Endocrinol. Metab. 53: 1223–1228.
Fujiwara, H., Torisu, M., Sugisaki, T., and Okano, H., 1981, Immune complex deposits in thyroid glands of patients with Graves’ disease, Clin. Immunol. Immunopathol. 19: 109–117.
Ohtaki, S., Endo, Y., Horinouchi, K., Yoshitake, S., and Ishikawa, E., 1981, Circulating thyroglobulin—antithyroglobulin immune complex in thyroid diseases usig enzyme-linked immunoassays, J. Clin. Endocrinol. Metab. 52: 239–246.
Van der Heide, D., Bolk, J. H., De Bruin, T. W. A., Van Es, L. A., Daha, M. R., Bussemaker, T. K., Goslings, B. M., and Querido, A., 1980, Circulating immune complexes and thyroid-stimulating immunoglobulins before, during, and after antithyroid drug therapy in patients with Graves’ disease, Lancet 1: 1376–1379.
Jordan, S. C., Johnston, W. H., and Bergstein, J. M., 1978, Immune complex glomerulonephritis mediated by thyroid antigens, Arch. Pathol. Lab. Med. 102: 530–533.
Horvath, F., Jr., Teague, P., Gaffney, E. F., Mars, D. R., and Fuller, T. J., 1979, Thyroid antigen associated immune complex glomerulonephritis in Graves’ disease, Am. J. Med. 67: 901–904.
Jordan, S. C., Buckingham, B., Sakai, R., and Olson, D., 1981, Studies of immune-complex glomerulonephritis mediated by human thyroglobulin, N. Engl. J. Med. 304: 1212–1215.
Okita, N., Kidd, A., Row, V. V., and Volpe, R., 1980, Sensitization of T-lymphocytes in Graves’ and Hashimoto’s disease, J. Clin. Endocrinol. Metab. 51: 316–320.
Okita, N., Topliss, D., Lewis, M., Row, V. V., and Volpe, R., 1981, T-lymphocyte sensitization in Graves’ and Hashimoto’s diseases confirmed by an indirect migration inhibition factor test, J. Clin. Endocrinol. Metab. 52: 523–527.
Okita, N., How, J., Topliss, D., Lewis, M., Row, V. V., and Volpe, R., 1981, Suppressor T lymphocyte dysfunction in Graves’ disease: Role of the H-2 histamine receptor-bearing suppressor T lymphocytes, J. Clin. Endocrinol. Metab. 53: 1002–1007.
Okita, N., Row, V. V., and Volpe, R., 1981, Suppressor T-lymphocyte deficiency in Graves’ disease and Hashimoto’s thyroiditis, J. Clin. Endocrinol. Metab. 52: 528–533.
MacLean, D. B., Miller, K. B., Brown, R., and Reichlin, S., 1981, Normal immunoregulation of in vitro antibody secretion in autoimmune thyroid disease, J. Clin. Endocrinol. Metab. 53: 801–805.
Tanaka, T., Katayama, S., Kuma, K., Tamai, H., Matsuzuka, F., and Hidaka, H., 1980, Clinical and pathological significance of sibling Graves’ disease, Acta Endocrinol. (Copenhagen) 94: 498–502.
Banovac, K., Zakarija, M., McKenzie, J. M., Witte, A., and Sekso, M., 1981, Absence of thyroid-stimulating antibody and long acting thyroid stimulator in relatives of Graves’ disease patients, J. Clin. Endocrinol. Metab. 53: 651–653.
Carey, C., Skosey, C., Pinnamaneni, K. M., Barsano, C. P., and DeGroot, L. J., 1980, Thyroid abnormalities in children of parents who have Graves’ disease: Possible pre-Graves’ disease, Metabolism 29: 369–376.
Tamai, H., Ohsako, N., Takeno, K., Fukino, O., Takahashi, H., Kuma, K., Kumagai, L. F., and Nagataki, S., 1980, Changes in thyroid function in eu-thyroid subjects with a family history of Graves’ disease: A follow-up study of 69 patients, J. Clin. Endocrinol. Metab. 51: 1123–1127.
Mather, B. A., Roberts, D. F., Scanlon, M. F., Mukhtar, E. D., Davies, T. F., Smith, B. R., and Hall, R., 1980, HLA antigens and thyroid autoantibodies in patients with Graves’ disease and their first degree relatives, Clin. Endocrinol. 12: 155–163.
Dallow, R. L., 1978, Reliability of orbital diagnostic tests: Ultrasonography, computerized tomography, and radiography, Ophthalmology 85: 1218–1228.
Kriss, J. P., and Mehdi, S. Q., 1979, Cell-mediated lysis of lipid vesicles containing eye muscle protein: Implications regarding pathogenesis of Graves’ ophthalmopathy, Proc. Natl. Acad. Sci. USA 76: 2003–2007.
Sergott, R. C., Felberg, N. T., Savino, P. J., Blizzard, J. J., and Schatz, N. J., 1981, Graves’ ophthalmopathy-immunologic parameters related to corticosteroid therapy, Invest. Ophthalmol. Vis. Sci. 20: 173–182.
Teng, C. S., Crombie, A. L., Hall, R., and Ross, W. M., 1980, An evaluation of supervoltage orbital irradiation for Graves’ ophthalmopathy, Clin. Endocrinol. 13: 545–551.
Wall, J. R., Strakosch, C. R., Fang, S. L., Ingbar, S. H., and Braverman, L. E., 1979, Thyroid binding antibodies and other immunological abnormalities in patients with Graves’ ophthalmopathy: Effect of treatment with cyclophosphamide, Clin. Endocrinol. 10: 79–91.
Bigos, S. T., Nisula, B. C., Daniels, G. H., Eastman, R. C., Johnston, H. H., and Kohler, P. O., 1979, Cyclophosphamide in the management of advanced Graves’ ophthalmopathy, Ann. Intern. Med. 90: 921–923.
Amino, N., Yuasa, T., Yabu, Y., Miyai, K., and Kumahara, Y., 1980, Exophthalmos in autoimmune thyroid disease, J. Clin. Endocrinol. Metab. 51: 1232–1234.
Tamai, H., Nakagawa, T., Ohsako, N., Fukino, O., Takahashi, H., Matsuzuka, F., Kuma, K., and Nagataki, S., 1980, Changes in thyroid functions in patients with euthyroid Graves’ disease, J. Clin. Endocrinol. Metab. 50: 108–112.
Buckingham, B. A., Costin, G., Roe, T. F., Weitzman, J. J., and Kogut, M. D., 1981, Hyperthyroidism in children-A reevaluation of treatment, Am. J. Dis. Child. 135: 112–117.
Freitas, J. E., Swanson, D. P., Gross, M. D., and Sisson, J. C., 1979, Iodine-131: Optimal therapy for hyperthyroidism in children and adolescents?, J. Nucl. Med. 20: 847–850.
Zonszein, J., Santangelo, R. P., Mackin, J. F., Lee, T. C., Coffey, R. J.,and Canary, J. J., 1979, Propranolol therapy in thyrotoxicosis—A review of 84 patients undergoing surgery, Am. J. Med. 66: 411–416.
Rubenfeld, S., Silverman, V. E., Welch, K. M. A., Mallette, L. E., and Kohler, P. O., 1979, Variable plasma propranolol levels in thyrotoxicosis, Med. Intell. 300: 353–354.
Riddell, J. G., Neill, J. D., Kelly, J. G., and McDevitt, D. G., 1980, Effects of thyroid dysfunction on propranolol kinetics, Clin. Pharmacol. Ther. 28: 565–574.
Feely, J., Forrest, A., Gunn, A., Hamilton, W., Stevenson, I., and Crooks, J., 1980, Propranolol dosage in thyrotoxicosis, J. Clin. Endocrinol. Metab. 51: 658–661.
Feek, C. M., Sawers, J. S. A., Irvine, W. J., Beckett, G. J., Ratcliffe, W. A., and Toft, A. D., 1980, Combination of potassium iodide and propranolol in preparation of patients with Graves’ disease for thyroid surgery, N. Engl. J. Med. 302: 883–885.
Emerson, C. H., and El-Zaheri, M. M. S., 1980, Potassium iodide and propranolol in Graves’ disease, N. Engl. J. Med. 303: 527–528.
Feely, J., Crooks, J., Forrest, A. L., Hamilton, W. F. D., Gunn, A., and Browning, M. C. K., 1981, Altered endocrine response to partial thyroidectomy in propranolol-prepared hyperthyroid patients, Clin. Endocrinol. 14: 597–604.
Nilsson, O. R., Melander, A., and Tegler, L., 1980, Effects and plasma levels of propranolol and metoprolol in hyperthyroid patients, Eur. J. Clin. Pharmacol. 18: 315–320.
Ross, P. J., Jones, M. K., and John, R., 1980, The effect of propranolol withdrawal on thyroid hormones in normal and hyperthyroid subjects, Clin. Endocrinol. 13: 27–31.
Rubin, P. C., 1981, Beta-blockers in pregnancy, N. Engl. J. Med. 305: 1323–1326.
Bradley, E. L., III, DiGirolamo, M., and Tarcan, Y., 1980, Modified subtotal thyroidectomy in management of Graves’ disease, Surgery 87: 623–629.
Rasmusson, B., Borgeskov, S., and Holm-Hansen, B., 1980, Changes in serum calcitonin in patients undergoing thyroid surgery, Surgery 146: 15–17.
Wilkin, T. J., Isles, T. E., Gunn, A., Crooks, J., and Beck, J. S., 1979, Short-term triiodothyronine in prevention of temporary hypothyroidism after subtotal thyroidectomy for Graves’ disease, Lancet 2: 63–66.
Sawers, J. S. A., Toft, A. D., Irvine, W. J., Brown, N. S., and Seth, J., 1980, Transient hypothyroidism after iodine-131 treatment of thyrotoxicosis, J. Clin. Endocrinol. Metab. 50: 226–229.
Tamai, H., Nakagawa, T., Takahashi, H., Ohsako, N., Fukino, O., Shinzato, R., Suematsu, H., Matsuzuka, F., Kuma, K., and Nagataki, S., 1980, Triiodothyronine suppression tests and TSH-releasing hormone tests before and after 1–131 therapy for Graves’ disease, J. Nucl. Med. 21: 240–245.
Vasily, D. B., and Tyler, W. B., 1980, Propylthiouracil-induced cutaneous vasculitis—Case presentation and review of the literature, J. Am. Med. Assoc. 243: 458–461.
Weiss, M., Hassin, D., and Bank, H., 1980, Propylthiouracil-induced hepatic damage, Arch. Intern. Med. 140: 1184–1185.
Greer, M. A., Kammer, H., and Bouman, D. J., 1977, Short-term antithyroid therapy for the thyrotoxicosis of Graves’ disease, N. Engl. J. Med. 297: 173–176.
Burr, W. A., Fitzgerald, M. G., and Hoffenberg, R., 1979, Relapse after short-term antithyroid therapy of Graves’ disease, N. Engl. J. Med. 300: 200.
Tamai, H., Nakagawa, T., Fukino, O., Ohsako, N., Shinzato, R., Suematsu, H., Kuma, K., Matsuzuka, F., and Nagataki, S., 1980, Thionamide therapy in Graves’ disease: Relation of relapse rate to duration of therapy, Ann. Intern. Med. 92: 488–490.
Slingerland, D. W., and Burrows, B. A., 1979, Long-term antithyroid treatment in hyperthyroidism, J. Am. Med. Assoc. 242: 2408–2410.
Wood, L. C., and Ingbar, S. H., 1979, Hypothyroidism as a late sequela in patients with Graves’ disease treated with antithyroid agents, J. Clin. Invest. 64: 1429–1436.
Yamamoto, M., Igarashi, T., Kimura, S., Tsukamoto, S., Togawa, K., and Ogata, E., 1979, Thyroid suppression test and outcome of hyperthyroidism treated with antithyroid drugs and triiodothyronine, J. Clin. Endocrinol. Metab. 48: 72–77.
Wilkin, T. J., Isles, T. E., Crooks, J., Gunn, A., and Beck, J. S., 1981, Patterns of change in the early (20-minute) radioiodine uptake during carbimazole treatment for Graves’ disease and their relationship to outcome, J. Clin. Endocrinol. Metab. 52: 1067–1072.
Gardner, D. F., and Utiger, R. D., 1979, The natural history of hyperthyroidism due to Graves’ disease in remission: Sequential studies of pituitary–thyroid regulation and various serum parameters, J. Clin. Endocrinol. Metab. 49: 417–421.
Cooper, D. S., Saxe, V. C., Maloof, F., and Ridgway, E. C., 1981, Studies of propylthiouracil using a newly developed radioimmunoassay, J. Clin. Endocrinol. Metab. 52: 204–213.
Kampmann, J. P., Mortensen, H. B., Bach, B., Waldorff, S., Kristensen, M. B., and Hansen, J. M., 1979, Kinetics of propylthiouracil in the elderly, Acta Med. Scand. 624: 93–98.
Skellern, G. G., Knight, B. I., Low, C. K. L., Alexander, W. D., McLarty, D. G., and Kalk, W. J., 1980, The pharmacokinetics of methimazole after oral administration of carbimazole and methimazole, in hyperthyroid patients, Br. J. Clin. Pharmacol. 9: 137–143.
Dahlberg, P. A., Karlsson, F. A., Lindström, B., and Wide, L., 1981, Studies of thyroid hormone and methimazole levels in patients with Graves’ disease on a standardized anti-thyroid drug regimen, Clin. Endocrinol. 14: 555–562.
Sugrue, D., McEvoy, M., Feely, J., and Drury, M. I., 1980, Hyperthyroidism in the land of Graves: Results of treatment by surgery, radioiodine and carbimazole in 837 cases, Q. J. Med. 193: 51–61.
Reynolds, L. R., and Kotchen, T. A., 1979, Antithyroid drugs and radioactive iodine—Fifteen years’ experience with Graves’ disease, Arch. Intern. Med. 139: 651–653.
Amir, S. M., Sullivan, R., and Ingbar, S. H., 1981, The effect of desialylation on the in vitro interaction of human chorionic gonadotropin with human thyroid plasma membranes, Endocrinology 109: 1203–1211.
Carayon, P., Amr, S., Nisula, B., and Lissitzky, S., 1981, Effect of carboxypeptidase digestion of the human choriogonadotropin molecule on its thyrotropic activity, Endocrinology 108: 1891–1898.
Davies, T. F., Taliadouros, G. S., Catt, K. J., and Nisula, B. C., 1979, Assessment of urinary thyrotropin-competing activity in choriocarcinoma and thyroid disease: Further evidence for human chorionic gonadotropin interacting at the thyroid cell membrane, J. Clin. Endocrinol. Metab. 49: 353–357.
Pekonen, F., and Weintraub, B. D., 1980, Interaction of crude and pure chorionic gonadotropin with the thyrotropin receptor, J. Clin. Endocrinol. Metab. 50: 280–285.
Carayon, P., Lefort, G., and Nisula, B., 1980, Interaction of human chorionic gonadotropin and human luteinizing hormone with human thyroid membranes, Endocrinology 106: 1907–1916.
Nikolai, T. F., Coombs, G. J., and McKenzie, A. K., 1981, Lymphocytic thyroiditis with spontaneously resolving hyperthyroidism and subacute thyroiditis, Arch. Intern. Med. 141: 1455–1458.
Inada, M., Nishikawa, M., Naito, K., Ishii, H., Tanaka, K., and Imura, H., 1981, Reversible changes of the histological abnormalities of the thyroid in patients with painless thyroiditis, J. Clin. Endocrinol. Metab. 52: 431–435.
Amino, N., Mori, H., Iwatani, Y., Tanizawa, O., Kawashima, M., Tsuge, I., Ibaragi, K., Kumahara, Y., and Miyai, K., 1982, High prevalence of transient post-partum thyrotoxicosis and hypothyroidism, Med. Intell. 306: 849–852.
Amino, N., Yabu, Y., Miki, T., Morimoto, S., Kumahara, Y., Mori, H., Iwatani, Y., Nishi, K., Nakatani, K., and Miyai, K., 1981, Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves’ disease and destruction-induced thyrotoxicosis, J. Clin. Endocrinol. Metab. 53: 113–116.
Weintraub, B. D., Gershengorn, M. C., Kourides, I. A., and Fein, H., 1981, Inappropriate secretion of thyroid-stimulating hormone, Ann. Intern. Med. 95: 339–351.
Kourides, I. A., Pekonen, F., and Weintraub, B. D., 1980, Absence of thyroid-binding immunoglobulins in patients with thyrotropin-mediated hyperthyroidism, J. Clin. Endocrinol. Metab. 51: 271–274.
Hamburger, J. I., 1980, Evolution of toxicity in solitary nontoxic autonomously functioning thyroid nodules, J. Clin. Endocrinol. Metab. 50: 1089–1093.
Mortimer, P. S., Tomlinson, I. W., and Rosenthal, F. D., 1981, Hemiaplasia of the thyroid with thyrotoxicosis, J. Clin. Endocrinol. Metab. 52: 152–155.
Melnick, J. C., and Stemkowski, P. E., 1981, Thyroid hemiagenesis (hockey stick sign): A review of the world literature and a report of four cases, J. Clin. Endocrinol. Metab. 52: 247–251.
Sharp, B., Reed, A. W., Tamagna, E. I., Geffner, D. L., and Hershman, J. M., 1981, Treatment of hyperthyroidism with sodium ipodate (Oragrafin) in addition to propylthiouracil and propranolol, J. Clin. Endocrinol. Metab. 53: 622–625.
Bhasin, S., Wallace, W., Lawrence, J. B., and Lesch, M., 1981, Sudden death associated with thyroid hormone abuse, Am. J. Med. 71: 887–890.
Nyström, E., Lindstedt, G., and Lundberg, P.-A., 1980, Minor signs and symptoms of toxicity in a young woman in spite of massive thyroxine ingestion, Acta Med. Scand. 207: 135–136.
Kabadi, U. M., and Eisenstein, A. B., 1980, Glucose intolerance in hyperthyroidism: Role of glucagon, J. Clin. Endocrinol. Metab. 50: 392–396.
Kabadi, U. M., and Eisenstein, A. B., 1980, Impaired pancreatic a-cell response in hyperthyroidism, J. Clin. Endocrinol. Metab. 51: 478–482.
Perez, G., Ungaro, B., Covelli, A., Morrone, G., Lombardi, G., Scopacasa, F., and Rossi, R., 1980, Altered glucoregulatory response to physiological infusions of epinephrine and glucagon in hyperthyroidism, J. Clin. Endocrinol. Metab. 51: 972–977.
Nilsson, O. R., Karlberg, B. E., and Söderberg, A., 1980, Plasma catecholamines and cardiovascular responses to hypoglycemia in hyperthyroidism before and during treatment with metoprolol or propranolol, J. Clin. Endocrinol. Metab. 50: 906–911.
Tse, J., Wrenn, R. W., and Kuo, J. F., 1980, Thyroxine-induced changes in characteristics and activities of (3-adrenergic receptors and adenosine 3’,5’-monophosphate and guanosine 3’,5’-monophosphate systems in the heart may be related to reputed catecholamine supersensitivity in hyperthyroidism, Endocrinology 107: 6–16.
Ginsberg, A. M., Clutter, W. E., Shah, S. D., and Cryer, P. E., 1981, Triiodothyronine-induced thyrotoxicosis increases mononuclear leukocyte 3-adrenergic receptor density in man, J. Clin. Invest. 67: 1785–1791.
Channick, B. J., Adlin, E. V., Marks, A. D., Dennenberg, B. S., McDonough, M. T., Chakko, C. S., and Spann, J. F., 1981, Hyperthyroidism and mitral-valve prolapse, N. Engl.J. Med. 305: 497–500.
Marks, A. D., Adlin, E. V., Dennenberg, B. S., and Channick, B.J., 1982, Increased incidence of mitral valve prolapse in chronic lymphocytic thyroiditis, Clin. Res. 30: 273A.
Bayley, T. A., Harrison, J. E., McNeill, K. G., and Mernagh, J. R., 1980, Effect of thyrotoxicosis and its treatment on bone mineral and muscle mass, J. Clin. Endocrinol. Metab. 50: 916–922.
Bouillon, R., Muls, E., and De Moor, P., 1980, Influence of thyroid function on the serum concentration of 1,25-dihydroxyvitamin D3, J. Clin. Endocrinol. Metab. 51: 793–797.
Haldimann, B., Kaptein, E. M., Singer, F. R., Nicoloff, J. T., and Massry, S. G., 1980, Intestinal calcium absorption in patients with hyperthyroidism, J. Clin. Endocrinol. Metab. 51: 995–997.
Cooper, D. S., Kaplan, M. M., Ridgway, E. C., Maloof, F., and Daniels, G. H., 1979, Alkaline phosphatase isoenzyme patterns in hyperthyroidism, Ann. Intern. Med. 90: 164–168.
Wiersinga, W. M., and Touber, J. L., 1980, The relation between gastrin, gastric acid and thyroid function disorders, Acta Endocrinol. (Copenhagen) 95: 341–349.
Seino, Y., Miyamoto, Y., Moridera, K., Taminato, T., Matsukura, S., and Imura, H., 1980, The role of the ß-adrenergic mechanism in the hypergastrinemia of hyperthyroidism, J. Clin. Endocrinol. Metab. 50: 368–370.
Lipson, A., Tah-Hsiung, H., and Nickoloff, E. L., 1980, Blood gastrin levels in hyperthyroidism, J. Clin. Endocrinol. Metab. 50: 176–178.
Swanson, J. W., Kelly, J. J., Jr., and McConahey, W. M., 1981, Neurologic aspects of thyroid dysfunction, Mayo Clin. Proc. 56: 504–512.
Puvanendran, K., Cheah, J. S., Naganathan, N., Yeo, P. P. B., and Wong, P. K., 1979, Neuromuscular transmission in thyrotoxicosis, J. Neurol. Sci. 43: 47–57.
Rockey, P. H., and Griep, R. J., 1980, Behavioral dysfunction in hyperthyroidism, Arch. Intern. Med. 140: 1194–1197.
Daneman, D., and Howard, N. J., 1980, Neonatal thyrotoxicosis: Intellectual impairment and craniosynostosis in later years, J. Pediatr. 97: 257–259.
Hollingsworth, D. R., and Mabry, C. C., 1976, Congenital Graves’ disease, Am. J. Dis. Child. 130: 148.
Kidd, G. S., Glass, A. R., and Vigersky, R. A., 1979, The hypothalamic—pituitary—testicular axis in thyrotoxicosis, J. Clin. Endocrinol. Metab. 48: 798–802.
Gray, R. S., Borsey, D. Q., Seth, J., Herd, R., Brown, N. S., and Clarke, B. F., 1980, Prevalence of subclinical thyroid failure in insulin-dependent diabetes, J. Clin. Endocrinol. Metab. 50: 1034–1037.
Crowe, J. P., Christensen, E., Butler, J., Wheeler, P., Doniach, D., Keenan, J., and Williams, R., 1980, Primary biliary cirrhosis: The prevalence of hypothyroidism and its relationship to thyroid autoantibodies and sicca syndrome, Gastroenterology 78: 1437–1441.
Gordon, M. B., Klein, I., Dekker, A., Rodnan, G. P., and Medsger, T. A., Jr., 1981, Thyroid disease in progressive systemic sclerosis: Increased frequency of glandular fibrosis and hypothyroidism, Ann. Intern. Med. 95: 431–435.
Lobo, E. D., Khan, M., and Tew, J., 1980, Community study of hypothyroidism in Down’s syndrome, Br. Med. J. 280: 1253.
Bahn, A. K., Mills, J. L., Snyder, P. J., Gann, P. H., Houten, L., Bialik, O., Hollmann, L., and Utiger, R. D., 1980, Hypothyroidism in workers exposed to polybrominated biphenyls, N. Engl. J. Med. 302: 31–33.
Smith, R. E., Jr., Adler, R. A., Clark, P., Brinck Johnsen, T., Tulloh, M. E., and Colton, T., 1981, Thyroid function after mantle irradiation in Hodgkin’s disease, J. Am. Med. Assoc. 245: 46–49.
Schimpff, S. C., Diggs, C. H., Wiswell, J. G., Salvatore, P. C., and Wiernik, P. H., 1980, Radiation-related thyroid dysfunction: Implications for the treatment of Hodgkin’s disease, Ann. Intern. Med. 92: 91–98.
Dussault, J. H., Letarte, J., Guyda, H., and Laberge, C., 1980, Lack of influence of thyroid antibodies on thyroid function in the newborn infant and on a mass screening program for congenital hypothyroidism, J. Pediatr. 96: 385–389.
Montoro, M., Collea, J. V., Frasier, S. D., and Mestman, J. H., 1981, Successful outcome of pregnancy in women with hypothyroidism, Ann. Intern. Med. 94: 31–34.
Bastenie, P. A., Bonnyns, M., and Vanhaelst, L., 1980, Grades of subclinical hypothyroidism in asymptomatic autoimmune thyroiditis revealed by the thyrotropin-releasing hormone test, Clin. Endocrinol. Metab. 51: 163–166.
Fisher, D. A., Dussault, J. H., Foley, T. P., Jr., Klein, A. H., LaFranchi, S., Lassen, P. R., Michell, M. L., Murphey, W. H., Walfish, P. G., 1979, Screening for congenital hypothyroidism: Results of screening one million North American infants, J. Pediatr. 94: 700–705.
Landau, H., Sack, J., Frucht, H., Palti, Z., Hochner-Celnikier, D., Rosenmann, A., 1980, Amniotic fluid 3,3’,5’-triiodothyronine in the detection of congenital hypothyroidism, J. Clin. Endocrinol. Metab. 50: 799–801.
Santos, A. D., Miller, R. P., Mathew, P. K., Wallace, W. A., Cave, W. T., Jr., Hinojosa, L., 1980, Echocardiographic characterization of the reversible cardiomyopathy of hypothyroidism, Am. J. Med. 68: 675–682.
Plotnick, G. D., Vassar, D. L., Parisi, A. F., Hamilton, B. P., Carliner, N. H., Fisher, M. L. 1979, Systolic time intervals in hypothyroidism: End organ function as a reflection of clinical status, Am. J. Med. Sci. 277: 263–268.
Sawin, C. T., Chopra, D., Azizi, F., Mannix, J. E., and Bacharach, P., 1979, The aging thyroid, increased prevalence of elevated serum thyrotropin levels in the elderly, J. Am. Med. Assoc. 242: 247–250.
Tieche, M., Lupi, G. A., Gutzwiller, F., Grob, P. J., Studer, H., and Bürgi, H., 1981, Borderline low thyroid function and thyroid autoimmunity, risk factors for coronary heart disease?, Br. Heart J. 46: 202–206.
Hay, I. D., Duick, D. S., Vlietstra, R. E., Maloney, J. D., and Pluth, J. R., 1981, Thyroxine therapy in hypothyroid patients undergoing coronary revascularization: A retrospective analysis, Ann. Intern. Med. 95: 456–458.
Parving, H.-H., Hansen, J. M., Nielsen, S. L., Rossing, N., Munck, O., and Lassen, N. A., 1979, Mechanisms of edema formation in myxedemaIncreased protein extravasation and relatively slow lymphatic drainage, N. Engl. J. Med. 301: 460–465.
Orr, W. C., Males, J. L., and Imes, N. K., 1981, Myxedema and obstructive sleep apnea, Am. J. Med. 70: 1061–1066.
Klein, I., Parker, M., Shebert, R., Ayyar, D. R., and Levey, G. S., 1981, Hypothyroidism presenting as muscle stiffness and pseudohypertrophy: Hoffmann’s syndrome, Am. J. Med. 70: 891–894.
Jakubovic, H. R., Salama, S. S. S., and Rosenthal, D., 1982, Multiple cutaneous focal mucinoses with hypothyroidism, Ann. Intern. Med. 96: 56–58.
Amino, N., Kuro, R., Yabu, Y., Takai, S.-I., Kawashima, M., Morimoto, S., Ichihara, K., Miyai, K., and Kumahara, Y., 1981, Elevated levels of circulating carcinoembryonic antigen in hypothyroidism, J. Clin. Endocrinol. Metab. 52: 457–462.
Agdeppa, D., Macaron, C., Mallik, T., and Schnuda, N. D., 1979, Plasma high density lipoprotein cholesterol in thyroid disease, J. Clin. Endocrinol. Metab. 49: 726–729.
Gorman, C. A., Jiang, N.-S., Ellefson, R. D., and Elveback, L. R., 1979, Comparative effectiveness of dextrothyroxine and levothyroxine in correcting hypothyroidism and lowering blood lipid levels in hypothyroid patients, J. Clin. Endocrinol. Metab. 49: 1–7.
Ingbar, J. C., Borges, M., Iflah, S., Kleinmann, R. E., Braverman, L. E., and Ingbar, S. H., 1982, Elevated serum thyroxine concentration in patients receiving “replacement” doses of levothyroxine, J. Endocrinol. Invest. 5: 77–85.
Rosenbaum, R. L., and Barzel, U. S., 1982, Levothyroxine replacement dose for primary hypothyroidism decreases with age, Ann. Intern. Med. 96: 53–55.
LaFranchi, S. H., 1979, Hypothyroidism, Pediatr. Clin. North Am. 26: 33–51.
Studer, H., and Ramelli, F., 1982, Simple goiter and its variants: Euthyroid and hyperthyroid multinodular goiters, Endocr. Rev. 3: 40–61.
Van Herle, A. J., Rich, P., Ljung, B.-M. E., Ashcraft, M. W., Solomon, D. H., and Keeler, E. B., 1982, The thyroid nodule, Ann. Intern. Med. 96: 221–232.
Bolk, J. H., Bussemaker, J. K., Elte, J. W. F., Haak, A., and Van Der Heide, D., 1979, Thyroid-stimulating immunoglobulins do not cause non-autonomous, autonomous, or toxic multinodular goitres, Lancet 2: 61–63.
Matte, R., Ste-Marie, L. G., Comtois, R., D’Amour, P., Lacroix, A., Chartrand, R., Poisson, R., and Bastomsky, C. H., 1981, The pituitary–thyroid axis after hemithyroidectomy in euthyroid man, J. Clin. Endocrinol. Metab. 53: 377–380.
Blichert-Toft, M., Egedorf, J., Christiansen, C., and Axelsson, C. K., 1979, Function of pituitary–thyroid axis after surgical treatment of nontoxic nodular goiter, Acta Med. Scand. 206: 15–19.
McCowen, K. D., Reed, J. W., and Fariss, B. L., 1980, The role of thyroid therapy in patients with thyroid cysts, Am. J. Med. 68: 853–855.
Rentsch, H., Studer, H., Frauchiger, B., and Siebenhüner, L., 1981, Topographical heterogeneity of basal and thyrotropin-stimulated adenosine 3’,5’-monophosphate in human nodular goiter, J. Clin. Endocrinol. Metab. 53: 514–521.
Van Sande, J., Mockel, J., Boeynaems, J. M., Dor, P., Andry, G., and Dumont J. E., 1980, Regulation of cyclic nucleotide and prostaglandin formation in normal human thyroid tissue and in autonomous nodules, J. Clin. Endocrinol. Metab. 50: 776–785.
Nagasaka, A., and Hidaka, H., 1980, Cyclic 3’,5’-nucleotide phosphodiesterase activities in the thyroid glands of patients with various disorders, J. Clin. Endocrinol. Metab. 50: 726–733.
Saito, K., Yamamota, K., Yoshida, S., Manabe, S., Suzuki, M., Takai, T., Saito, T., Kuzuya, T., and Moriyama, S.-I., 1981, Goitrous hypothyroidism due to iodide-trapping defect, J. Clin. Endocrinol. Metab. 53: 1267–1272.
Eggo, M. C., Burrow, G. N., Alexander, N. M., and Gordon, J. H., 1980, Iodination and the structure of human thyroglobulin, J. Clin. Endocrinol. Metab. 51: 7–11.
Cooper, D. S., Axelrod, L., DeGroot, L.J., Vickery, A. Lin, and Maloof, F., 1981, Congenital goiter and the development of metastatic follicular carcinoma with evidence for a leak of nonhormonal iodide: Clinical, pathological, kinetic, and biochemical studies and a review of the literature, J. Clin. Endocrinol. Metab. 52: 294–306.
Gaitan, E., Medina, P., DeRouen, T. A., and Zia, M. S., 1980, Goiter prevalence and bacterial contamination of water supplies, J. Clin. Endocrinol. Metab. 51: 957–961.
Weiss, M., Kasper, D., and Ingbar, S. H., 1982, A specific, saturable binding site for thyrotropin (TSH) in Yersinia enterocolitica and E. coli, Clin. Res. 30: 494A.
Colacchio, T. A., LoGerfo, P., and Feind, C. R., 1980, Fine needle cytologic diagnosis of thyroid nodules, Am. J. Surg. 140: 568–571.
Miller, J. M., Hamburger, J. I., and Kini, S., 1979, Diagnosis of thyroid nodules, J. Am. Med. Assoc. 241: 481–484.
Miller, J. M., Hamburger, J. I., and Kini, S. R., 1981, The needle biopsy diagnosis of papillary thyroid carcinoma, Cancer 48: 989–993.
Stepanas, A. V., Samaan, N. A., Hill, C. S., Jr., and Hickey, R. C., 1979, Medullary thyroid carcinoma, Cancer 43: 825–837.
Block, M. A., Jackson, C. E., Greenawald, K. A., and Yott, J. B., 1980, Clinical characteristics distinguishing hereditary from sporadic medullary thyroid carcinoma: Treatment implications, Arch. Surg. (Chicago) 115: 142–148.
Lamberg, B.-A., Reissel, P., Stenman, S., Koivuniemi, A., Ekblom, M., Mäkinen, J., and Franssila, K., 1981, Concurrent medullary and papillary thyroid carcinoma in the same thyroid lobe and in siblings, Acta Med. Scand. 209: 421–424.
Deftos, L. J., Bone, H. G., III, Parthemore, J. G., and Burton, D. W., 1980, Immunohistological studies of medullary thyroid carcinoma and C cell hyperplasia, J. Clin. Endocrinol. Metab. 51: 857–862.
Schneider, A. B., Bekerman, C., Favus, M., Frohman, L. A., Gonzalez, C., Ryo, U. Y., Sievertsen, G., and Pinsky, S., 1981, Continuing occurrence of thyroid nodules after head and neck irradiation, Ann. Intern. Med. 94: 176–180.
McDougall, I. R., Coleman, C. N., Burke, J. S., Saunders, W., and Kaplan, H. S., 1980, Thyroid carcinoma after high-dose external radiotherapy for Hodgkin’s disease, Cancer 45: 2056–2060.
Compagno, J., and Oertel, J. E., 1980, Malignant lymphoma and other lymphoproliferative disorders of the thyroid gland, Am. J. Clin. Pathol. 74: 1–11.
Carayon, P., Morvan, C. T., Castanas, E., and Tubiana, M., 1980, Human thyroid cancer: Membrane thyrotropin binding and adenylate cyclase activity, J. Clin. Endocrinol. Metab. 51: 915–920.
Schlumberger, M., Charbord, P., Fragu, P., Lumbroso, J., Parmentier, C., and Tubiana, M., 1980, Circulating thyroglobulin and thyroid hormones in patients with metastases of differentiated thyroid carcinoma: Relationship to serum thyrotropin levels, J. Clin. Endocrinol. Metab. 51: 513–519.
Fui, S. C. N. T., Hoffenberg, R., Maisey, M. N., and Black, E. G., 1979, Serum thyroglobulin concentrations and whole-body radioiodine scan in follow-up of differentiated thyroid cancer after thyroid ablation, Br. Med. J. 2: 298–300.
Ashcraft, M. W., and van Herle, A. J., 1981, The comparative value of serum thyroglobulin measurements and iodine 131 total body scans in the follow-up study of patients with treated differentiated thyroid cancer, Am. J. Med. 71: 806–814.
Schneider, A. B., Line, B. R., Goldman, J. M., and Robbins, J., 1981, Sequential serum thyroglobulin determinations, 131I scans, and 131I uptakes after triiodothyronine withdrawal in patients with thyroid cancer, J. Clin. Endocrinol. Metab. 53: 1199–1206.
Young, R. L., Mazzaferri, E. L., Rahe, A. J., and Dorfman, S. G., 1980, Pure follicular thyroid carcinoma: Impact of therapy in 214 patients, J. Nucl. Med. 21: 733–737.
Mazzaferri, E. L., and Young, R. L., 1981, Papillary thyroid carcinoma: A 10 year follow-up report of the impact of therapy in 576 patients, Am. J. Med. 70: 511–518.
DeGroot, L. J., and Reilly, M., 1982, Comparison of 30- and 50-mCi doses of iodine-131 for thyroid ablation, Ann. Intern. Med. 96: 51–53.
Chung, C. T., Sagerman, R. H., Ryoo, M. C., King, G. A., Yu, W. S., Dalai, P. S., and Emmanuel, I. G., 1980, External irradiation for malignant thyroid tumors, Radiology 136: 753–756.
Shapiro, S., Slone, D., Kaufman, D. W., Rosenberg, L., Miettinen, O. S., Stolley, P. D., Knapp, R. C., Leavitt, T., Jr., Watring, W. G., Rosenshein, N. B., and Schottenfeld, D., 1980, Use of thyroid supplements in relation to the risk of breast cancer, J. Am. Med. Assoc. 244: 1685–1687.
Hedley, A. J., Spiegelhalter, D. J., Jones, S. J., Clements, P., Bewsher, P. D., Simpson, J. G., and Weir, R. D., 1981, Breast cancer in thyroid disease: Fact or fallacy?, Lancet 1: 131–133.
Cerbon, M.-A., Pichon, M.-F., and Milgrom, E., 1981, Thyroid hormone receptors in human breast cancer, Cancer Res. 41: 4167–4173.
Spitz, I. M., Roith, D. L., Hirsch, H., Carayon, P., Pekonen, F., Liel, Y., Sobel, R., Chorer, Z., and Weintraub, B., 1981, Increased high-molecularweight thyrotropin with impaired biologic activity in a euthyroid man, N. Engl. J. Med. 304: 278–282.
Beamer, W. G., Eicher, E. M., Maltais, L. J., and Southard, J. L., 1981, Inherited primary hypothyroidism in mice, Science 212: 61–63.
Smeds, S., Anderberg, B., Boeryd, B., Ericson, L. E., Gillquist, J., and Persliden, J., 1981, The nude mouse: A possible experimental model for investigation of human thyroid tissue, J. Endocrinol. Invest. 4: 11–15.
Sternthal, E., Like, A. A., Sarantis, K., and Braverman, L. E., 1981, Lymphocytic thyroiditis and diabetes in the BB/W rat: A new model of autoimmune endocrinopathy, Diabetes 3: 1058–1061.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Plenum Publishing Corporation
About this chapter
Cite this chapter
Woeber, K.A., Braverman, L.E. (1985). The Thyroid. In: Ingbar, S.H. (eds) Contemporary Endocrinology. Contemporary Endocrinology, vol 2. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4817-7_3
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4817-7_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4819-1
Online ISBN: 978-1-4684-4817-7
eBook Packages: Springer Book Archive